Diagnostic and prognostic value of procalcitonin blood level studies in patients with purulent-inflammatory diseases of the uterus and its appendages

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract


The authors believe, that patients with purulent-inflammatory diseases of the uterus and its appendages, complicated widespread peritonitis, for values of blood procalcitonin level to 1.13 ng/mL can talk about abdominal sepsis without organ failure, at the level of 1.13-4.5 ng/mL should include developing organ failure 1-2 systems, that is, in this category of patients with high probability there is heavy abdominal sepsis with multiple organ failure laboratory level - disorders of the functioning of core indicators while maintaining homeostasis. If the levels of procalcitonin exceed 4.5 ng/ml, this indicates heavy abdominal sepsis with multiple organ failure in the progression multiple organ failure in multiple organ inconsistency. Reduction of procalcitonin in the postoperative period reflects a decrease in the body's inflammatory response, and reliable increase in the level of procalcitonin (and/or the absence of reduction) from the third day indicates the progression of the disease, which allows us to offer a method in monitoring and evaluating the effectiveness of the therapy.

Full Text

Restricted Access

About the authors

Biuzand Vazgenovich Arakelian

Saint Petersburg State Pediatric Medical University

Email: byuzand@mail.ru
MD, PhD, Dr Med Sci, Professor. Department of Children Gynecology and Female Reproductology, Faculty of Postgraduate Education

Nadezda Anatolyevna Kokhreidze

Saint Petersburg State Pediatric Medical University

Email: kokhreidze@mail.ru
MD, PhD, Associate Professor. Department of Children Gynecology and Female Reproductology, Faculty of Postgraduate Education

References

  1. Антонов А. Г., Байбарина Е. Н., Соколовская Ю. В. Объединенные диагностические критерии сепсиса у новорожденных. Вопросы гинекологии, акушерства и перинатологии. 2005; 4 (5-6): 113-5.
  2. Баранов А. А. Руководство по педиатрии (том Неонатология) / под ред. А. А. Баранова. М.: Медицина. 2007.
  3. Боженков Ю. Г., Коцовский М. И., Плисецкий А. В., Цеханович Н. Т., Пархоменко К. К. Хирургическая тактика при распространённом перитоните в неотложной гинекологии. Акуш. и гинек. 2001; 5: 51-2.
  4. Гринёв М. В., Громов М. И., Комраков В. Е. Хирургический сепсис. СПб. 2001.
  5. Краснопольский В. И., Буянова С. Н., Щукина Н. А. Гнойная гинекология. М.: МЕД-прессинформ. 2006.
  6. Серов В. Н., Панкова Е. О. Критерии прогноза осложнений и выбора основного метода лечения у больных с гнойно-воспалительными заболеваниями матки и придатков. Материалы VI Российского форума «Мать и дитя». 2004; 479-80.
  7. Шляпников С. А., Насер Н. Р., Аджамов Б. М. Проблема антибактериальной терапии в отделении реанимации и интенсивной терапии. Инфекции в хирургии. 2010; 8 (1): 47-8.
  8. Mullera B., Kenneth L. Becker. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss med wkly. 2001; 131: 595-602.
  9. Simon L., Gauvin F., Devendra Amre K., Saint-Louis P., Lacroix J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 2004: 206-17.
  10. Vincent J. L., de Mendonza A., Cantraine F. et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit. Care Med. 1998; 26: 1793-800.
  11. Vincent J. L., Moreno R., Takala J., Willats S. The SOFA (sepsis - related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996; 22: 707-10.

Statistics

Views

Abstract - 377

PDF (Russian) - 266

Cited-By


PlumX

Dimensions


Copyright (c) 2015 Arakelian B.V., Kokhreidze N.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies